Moreover, the analysis of GSE26713 (Homminga et al., 2011) also showed an increased expression of MSMO1,HMGCS1, SREBF2, and HMGCR in T-ALL cell lines and patients (Supplementary Figures S7A, B), but MVD showed no significant difference (Supplementary Figure S6B). This evidence concerns the gene SREBF2 and acute lymphoblastic leukemia.